Recherche
-
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial
(Lancet Oncology. vol. 21, n° 3, pp. 446-455, 2020)Article de revue -
Factors associated with daptomycin consumption in French hospitals between 2019 and 2020: a nationwide surveillance study
(Infectious Diseases Now. vol. 52, n° 2, 2022-12-08)Article de revue -
Survival after breast cancer according to participation in organised or opportunistic screening and deprivation
(Cancer Epidemiology. vol. 82, 2023-02)Article de revue -
Poison control centres and alternative forms of communication: comparison of response rates between text message and telephone follow-up
(Clinical Toxicology. pp. 1-7, 2022-03-21)Article de revue -
Relationship Between Scorpion Stings Events and Environmental Conditions in Mainland France
(Journal of Medical Entomology, 2021-07-05)Article de revue -
Determinants of functional decline in older adults experiencing cancer (the INCAPAC study)
(Journal of Geriatric Oncology. vol. 10, n° 6, pp. 913-920, 2019-11)Article de revue -
The Associations Between Child-Care Services During the Preschool Years and High School Graduation: A 20-Year Longitudinal Population-Based Study
(Journal of Developmental and Behavioral Pediatrics, 2021-11-03)Article de revue -
Trabectedin plus durvalumab in patients with advanced pretreated soft tissue sarcoma and ovarian carcinoma (TRAMUNE): an open-label, multicenter phase Ib study
(Clinical Cancer Research, 2021-12-29)Article de revue -
Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre
(European Radiology. pp. 1-8, 2021-10-13)Article de revue -
Cabozantinib in patients with advanced osteosarcomas and Ewing sarcomas: A French Sarcoma Group (FSG)/US National Cancer Institute phase II collaborative study
(Ann. Oncol.. vol. 29, pp. 1, 2018-10)Article de revue